Close

Product Liability Lawyer Blog

Updated:

Pradaxa Makers Banking on New Antidote to Win Sales War with Warfarin

Patients who have a serious health condition known as atrial fibrillation (Afib) are required to take blood-thinning medications to prevent stroke, heart disease, pulmonary embolism (PE) and other serious clotting disorders. Traditionally, this means taking Warfarin. Warfarin is a long existing blood thinning medication now available in generic form. While…

Updated:

RomneyCare Increases Hip and Knee Replacements in Massachusetts

According to a recent report from the Boston Business Journal, total knee replacement and hip replacement numbers are on the rise across the Commonwealth of Massachusetts due in large part to the government health program better known as “RomneyCare.” With more people having access to better healthcare coverage, researchers have…

Updated:

Total Knee Replacement Alternatives: Artificial Cartilage

Total knee replacement surgery involves a surgeon removing a patient’s deteriorating natural knee, cutting bone and tissues, and implanting an artificial knee. This is a highly invasive surgery with a considerably lengthy and painful recovery, even if everything goes according to plan. Traditionally, total knee replacement was largely reserved for…

Updated:

Boehringer Ingelheim Files for FDA Approval for Pradaxa Antidote

Pradaxa is an oral anticoagulant similar to Xarelto and Eliquis, which has been prescribed to patients with a serious medical condition known as atrial fibrillation (Afib) as an alternative to Warfarin and other traditional blood thinning agents. Afib patients are higher risk for serious clotting disorders that can lead to…

Updated:

Testosterone Replacement Therapy: Risks and Benefits

Anyone who has ever watched a football game or a NASCAR race has probably seen his share of testosterone replacement therapy (TRT) advertisements. This is not an accident. Drug makers are spending millions of dollars on advertising testosterone hormone therapy (HRT) supplements to men of all ages. Drug companies are…

Updated:

Xarelto Makers Set Sights on Warfarin Despite Bleeding Risk

Xarelto, like Eliquis and Pradaxa, is a blood thinner known as a New Oral Anticoagulant (NOAC) or Factor Xa Inhibitor. Patients at risk for heart disease or with clotting disorders are often required to take an anticoagulant to prevent stroke and other serious medical conditions. The traditional therapy used by…

Updated:

Pradaxa Maker Cuts Workforce Due to Lawsuits and Decreased Sales

Pradaxa maker, Boehringer Ingelheim, has announced it will be reducing its workforce in New England as well as internationally as it faces defective products lawsuits and declining sales of its blood-thinning medication. Pradaxa is a member of a class of drugs known as New Oral Anticoagulants (NOACs) that is marketed…

Updated:

Federal Judge Pushes Parties to Settle 70,000 Transvaginal Mesh Lawsuits

Many women who suffered from urinary incontinence and other medical conditions were told transvaginal mesh (TVM) could solve these problems. Essentially, doctors insert a medical device consisting of a surgical grade mesh, and a suspension system such as sling, into patients in an effort to provide additional support to the…

Contact Us